Robert Brashear

1.6k total citations
19 papers, 385 citations indexed

About

Robert Brashear is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Robert Brashear has authored 19 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 7 papers in Psychiatry and Mental health and 4 papers in Neurology. Recurrent topics in Robert Brashear's work include Alzheimer's disease research and treatments (11 papers), Dementia and Cognitive Impairment Research (7 papers) and Neurological Disease Mechanisms and Treatments (3 papers). Robert Brashear is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Dementia and Cognitive Impairment Research (7 papers) and Neurological Disease Mechanisms and Treatments (3 papers). Robert Brashear collaborates with scholars based in United States, Belgium and United Kingdom. Robert Brashear's co-authors include Andrew Kertesz, Michael J. Light, Mervin Blair, Wilda Davidson, Sarah Jesso, Jeffrey S. Nye, Klaus Häger, Mary Sano, Bonnie M. Davis and Steven Caras and has published in prestigious journals such as The American Journal of Surgery, European Radiology and Alzheimer s & Dementia.

In The Last Decade

Robert Brashear

18 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Brashear United States 8 195 132 86 77 74 19 385
Hyun Jeong Han South Korea 16 243 1.2× 211 1.6× 59 0.7× 73 0.9× 119 1.6× 51 595
Mei‐Chuan Chou Taiwan 12 198 1.0× 111 0.8× 51 0.6× 25 0.3× 58 0.8× 29 408
V. Canonico Italy 9 212 1.1× 128 1.0× 71 0.8× 36 0.5× 30 0.4× 27 635
Erik Bertoletti Italy 10 252 1.3× 127 1.0× 80 0.9× 38 0.5× 64 0.9× 17 441
Magda Castellvı́ Spain 14 265 1.4× 226 1.7× 170 2.0× 66 0.9× 35 0.5× 23 590
M Maggini Italy 7 159 0.8× 108 0.8× 49 0.6× 36 0.5× 99 1.3× 14 385
E Łuczywek Poland 10 270 1.4× 264 2.0× 83 1.0× 68 0.9× 61 0.8× 28 622
B. Wasiak Poland 9 235 1.2× 250 1.9× 58 0.7× 42 0.5× 60 0.8× 13 547
F. Latour France 12 318 1.6× 159 1.2× 124 1.4× 17 0.2× 84 1.1× 28 577
Sabine Nore Norway 7 286 1.5× 198 1.5× 66 0.8× 136 1.8× 21 0.3× 7 453

Countries citing papers authored by Robert Brashear

Since Specialization
Citations

This map shows the geographic impact of Robert Brashear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Brashear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Brashear more than expected).

Fields of papers citing papers by Robert Brashear

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Brashear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Brashear. The network helps show where Robert Brashear may publish in the future.

Co-authorship network of co-authors of Robert Brashear

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Brashear. A scholar is included among the top collaborators of Robert Brashear based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Brashear. Robert Brashear is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Weıntraub, Sandra, María C. Carrillo, Sarah Tomaszewski Farias, et al.. (2018). Measuring cognition and function in the preclinical stage of Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 4(1). 64–75. 91 indexed citations
3.
Martens, Roland M., Silvia Ingala, Ronald A. van Schijndel, et al.. (2017). The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study. European Radiology. 28(3). 1215–1226. 7 indexed citations
4.
5.
Häger, Klaus, et al.. (2014). Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease. Neuropsychiatric Disease and Treatment. 10. 391–391. 58 indexed citations
6.
Novak, Gerald, Steven Einstein, Luc Bracoud, et al.. (2014). IC‐P‐042: RATES OF CHANGE IN BRAIN VOLUME WITH SUBCUTANEOUS BAPINEUZUMAB. Alzheimer s & Dementia. 10(4S_Part_6). 1 indexed citations
7.
Liu, Enchi, Jianing Di, Kevin Booth, et al.. (2014). IC‐P‐037: EVALUATION OF CEREBRAL GRAY MATTER AND PONS AS REFERENCE REGIONS FOR AMYLOID PET: RESULTS FROM A BAPINEUZUMAB SUBCUTANEOUS PHASE 2 TRIAL. Alzheimer s & Dementia. 10(4S_Part_6). 1 indexed citations
8.
9.
10.
11.
Streffer, Johannes, Kaj Blennow, Stephen Salloway, et al.. (2013). O1–06–02: Effect of bapineuzumab on CSF p‐tau and t‐tau in mild‐to‐moderate Alzheimer's disease: Results from two phase III trials in APOE‐ε4 carriers and noncarriers. Alzheimer s & Dementia. 9(4S_Part_3). 1 indexed citations
12.
Lyketsos, Constantine G., María C. Carrillo, J. Michael Ryan, et al.. (2011). Perspectives Neuropsychiatric symptoms in Alzheimer's disease. 4 indexed citations
13.
Sperling, Reisa A., Stephen Salloway, Michael Arrighi, et al.. (2011). P4‐438: Revised estimates of incidence and risk factors for amyloid related imaging abnormalities (ARIA) in the phase 2 studies of bapineuzumab for mild‐to‐moderate Alzheimer's disease. Alzheimer s & Dementia. 7(4S_Part_25). 5 indexed citations
14.
Kertesz, Andrew, Michael J. Light, Mervin Blair, et al.. (2008). Galantamine in Frontotemporal Dementia and Primary Progressive Aphasia. Dementia and Geriatric Cognitive Disorders. 25(2). 178–185. 144 indexed citations
15.
Erkinjuntti, Timo, Serge Gauthier, R. Morris Bullock, et al.. (2008). Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6). Journal of Psychopharmacology. 22(7). 761–768. 17 indexed citations
16.
Caras, Steven, et al.. (1996). Pancreatic Cancer Presenting With Paraneoplastic Gastroparesis. The American Journal of the Medical Sciences. 312(1). 34–36. 19 indexed citations
17.
Caras, Steven, et al.. (1996). Pancreatic Cancer Presenting With Paraneoplastic Gastroparesis. The American Journal of the Medical Sciences. 312(1). 34–36. 14 indexed citations
18.
Hudson, Reggie L., et al.. (1990). A eutectic mixture with medicinal applications. Journal of Chemical Education. 67(2). 156–156. 6 indexed citations
19.
Friedenberg, Zachary B. & Robert Brashear. (1956). Bone growth following partial resection of the epiphyseal cartilage. The American Journal of Surgery. 91(3). 362–364. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyun Jeong Han Breakdown of academic impact, for papers by Mei‐Chuan Chou Breakdown of academic impact, for papers by V. Canonico Breakdown of academic impact, for papers by Erik Bertoletti Breakdown of academic impact, for papers by Magda Castellvı́ Breakdown of academic impact, for papers by M Maggini Breakdown of academic impact, for papers by E Łuczywek Breakdown of academic impact, for papers by B. Wasiak Breakdown of academic impact, for papers by F. Latour Breakdown of academic impact, for papers by Sabine Nore
Rankless by CCL
2026